A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy

Linwah Yip, Laura I. Wharry, Michaele J. Armstrong, Ari Silbermann, Kelly L. McCoy, Michael T. Stang, Nobuyuki P. Ohori, Shane O. Lebeau, Christopher Coyne, Marina N. Nikiforova, Julie E. Bauman, Jonas T. Johnson, Mitch E. Tublin, Steven P. Hodak, Yuri E. Nikiforov, Sally E. Carty

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Abstract

OBJECTIVE:: To test whether a clinical algorithm using routine cytological molecular testing (MT) promotes initial total thyroidectomy (TT) for clinically significant thyroid cancer (sTC) and/or correctly limits surgery to lobectomy when appropriate. BACKGROUND:: Either TT or lobectomy is often needed to diagnose differentiated thyroid cancer. Determining the correct extent of initial thyroidectomy is challenging. METHODS:: After implementing an algorithm for prospective MT of in-house fine-needle aspiration biopsy specimens, we conducted a single-institution cohort study of all patients (N = 671) with nonmalignant cytology who had thyroidectomy between October 2010 and March 2012, cytological diagnosis using 2008 Bethesda criteria, and 1 or more indications for thyroidectomy by 2009 American Thyroid Association guidelines. sTC was defined by histological differentiated thyroid cancer of 1 cm or more and/or lymph node metastasis. Cohort 2 patients did not have MT or had unevaluable results. In cohort 1, MT for a multigene mutation panel was performed for nonbenign cytology, and positive MT results indicated initial TT. RESULTS:: MT guidance was associated with a higher incidence of sTC after TT (P = 0.006) and a lower rate of sTC after lobectomy (P = 0.03). Without MT results, patients with indeterminate (follicular lesion of undetermined significance/follicular or oncocytic neoplasm) cytology who received initial lobectomy were 2.5 times more likely to require 2-stage surgery for histological sTC (P < 0.001). In the 501 patients with non-sTC for whom lobectomy was the appropriate extent of surgery, lobectomy was correctly performed more often with routine preoperative MT (P = 0.001). CONCLUSIONS:: Fine-needle aspiration biopsy MT for BRAF, RAS, PAX8-PPARγ, and RET-PTC expedites optimal initial surgery for differentiated thyroid cancer, facilitating succinct definitive management for patients with thyroid nodules.

Original languageEnglish (US)
Pages (from-to)163-168
Number of pages6
JournalAnnals of surgery
Volume260
Issue number1
DOIs
StatePublished - Jul 2014
Externally publishedYes

Keywords

  • indeterminate nodule
  • molecular markers
  • thyroid
  • thyroid cancer
  • thyroidectomy

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy'. Together they form a unique fingerprint.

Cite this